Institutional Biosafety Committee

The purpose of the Georgetown University Institutional Biosafety Committee (IBC) is to provide regulatory guidance to research personnel to ensure the safe conduct of biomedical research projects, while maintaining compliance with local, state, and federal requirements. Protocol approvals are required for research involving the use of infectious microorganisms, recombinant DNA, and biological toxins. The IBC carries out these functions pursuant to requirements set forth by the National Institutes of Health, and NIH Guidelines For Research Involving Recombinant DNA Molecules. EH&S performs risk assessments in order to develop biosafety policies and procedures and to set containment levels that ensure the safety of Georgetown University employees and the surrounding community. The IBC serves to provide protocol review and approval, as well as, for amended protocols. A formal letter is issued to the Principal Investigator, and other regulatory stakeholders, to document that the research project has been approved by the committee.

Membership Roster 2018-2019

Vicente Notario, Ph.D., Chair
Professor, Radiation Medicine

John Casey, Ph.D. Vice-Chair
Assoc. Professor, Microbio & Immunology

Seema Agarwal, Ph.D.
Assoc. Professor, Pathology

Deborah Berry, Ph.D.
Asst. Professor, Oncology

Marta Catalfamo, Ph.D.
Assoc. Professor, Microbio & Immunology

Danelle Chavez, MPH
Sr. Occupational Biosafety Manager

Julie Fischer, Ph.D.
Assoc. Professor, Microbio & Immunology

Patricia Foley, DVM
Professor, School of Medicine

Susan Martin, M.S., CSHM
Executive Dir., Environ. Health & Safety

Leonard Rosenthal, Ph.D.
Professor, Microbiology & Immunology

Claire Standley, Ph.D.
Asst. Professor, International Health

Ms. Susan Commins Gallagher
Community Member

Ms. Zelda R. McDonald
Community Member

Robin Tucker, DVM
Sr. Clinical Veterinarian

Rodney Freeman
IBC Administrator